We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Troponin Elevation in Consecutive Patients With Hip Fracture

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01015105
Recruitment Status : Completed
First Posted : November 18, 2009
Last Update Posted : November 8, 2016
Sponsor:
Information provided by (Responsible Party):
Marjatta Strandberg, Turku University Hospital

Brief Summary:

The aims of this study is to study the occurrence of the troponin elevations, ECG changes, and cardiac symptoms in unselected consecutive patients with hip fracture.

Followup will be carried out up to one year period.


Condition or disease Intervention/treatment
Hip Fracture Other: observation

Study Type : Observational
Actual Enrollment : 200 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Troponin Elevation in Consecutive Patients With Hip Fracture
Study Start Date : February 2009
Primary Completion Date : May 2010
Study Completion Date : January 2016

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Group/Cohort Intervention/treatment
patients with hip fracture Other: observation
observation




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 110 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
200 patients with hip fracture
Criteria

Inclusion Criterion:

  • Hip fracture diagnosed in Turku Univeristy Hospital between October 2009 and May 2010

Exclusion Criterion:

  • Patient refusal

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01015105


Locations
Finland
Turku University Hospital
Turku, Finland
Sponsors and Collaborators
Turku University Hospital

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Marjatta Strandberg, MD, Turku University Hospital
ClinicalTrials.gov Identifier: NCT01015105     History of Changes
Other Study ID Numbers: TnT in Hip Fracture
First Posted: November 18, 2009    Key Record Dates
Last Update Posted: November 8, 2016
Last Verified: November 2016

Keywords provided by Marjatta Strandberg, Turku University Hospital:
patients with hip fracture

Additional relevant MeSH terms:
Fractures, Bone
Hip Fractures
Wounds and Injuries
Femoral Fractures
Hip Injuries
Leg Injuries